Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review

Pediatric Transplantation

Volumn 14, Issue 3, 2010, Pages 314-325

  Vinai, Modini ^a,b   Waber, Pamela ^a   Seikaly, Mouin G ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Children; FSGS; Kidney; Recurrence; Transplant

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ARGATROBAN; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRIN; OKT 3; PROTEIN A; RAPAMYCIN; RITUXIMAB; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; WARFARIN; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

AGE; ARTICLE; CARDIOVASCULAR DISEASE; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG TREATMENT FAILURE; ETHNIC DIFFERENCE; FOCAL GLOMERULOSCLEROSIS; GENE MUTATION; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HYPERCHOLESTEROLEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOADSORPTION; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; NEPHROSIS; NEPHROTIC SYNDROME; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PLASMAPHERESIS; POSTOPERATIVE THROMBOSIS; PROTEINURIA; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SEX DIFFERENCE; THROMBOPHILIA; VASCULAR DISEASE; ALLOTRANSPLANTATION; CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CALCINEURIN INHIBITORS; CHILD; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; RECURRENCE; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77950650794     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01261.x     Document Type: Article

References (108)

1. Rich AR. A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bulletin of the Johns Hopkins Hospital 1957 : 100 : 173 186.
2. D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 2003 : 23 : 117 134. (Pubitemid 36397094)
3. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: A working proposal. Am J Kidney Dis 2004 : 43 : 368 382.
4. Yoshikawa N, Ito H, Akamatsu R, et al. Focal segmental glomerulosclerosis with and without nephrotic syndrome in children. J Pediatr 1986 : 109 : 65 70. (Pubitemid 16099844)
5. Bonilla-Felix M, Parra C, Dajani T, et al. Changing patterns in the histopathology of idiopathic nephrotic syndrome in children.[see comment]. Kidney Int 1999 : 55 : 1885 1890. (Pubitemid 29197976)
6. Chesney R. The changing face of childhood nephrotic syndrome. Kidney Int 2004 : 66 : 1294 1302. (Pubitemid 39121048)
7. Hogg R, Middleton J, Vehaskari VM. Focal segmental glomerulosclerosis - epidemiology aspects in children and adults. Pediatr Nephrol 2007 : 22 : 183 186. (Pubitemid 44964316)
8. Chun MJ, Korbet SM, Schwartz MM, Lewis EJ. Focal segmental glomerulosclerosis in nephrotic adults: Presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 2004 : 15 : 2169 2177.
9. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 2004 : 44 : 815 825. (Pubitemid 39445913)
10. Korbet SM, Schwartz MM, Lewis EJ. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy. Am J Kidney Dis 1994 : 23 : 773 783. (Pubitemid 24173558)
11. Deegens JK, Steenbergen EJ, Wetzels JF, Deegens JKJ, Wetzels JFM. Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med 2008 : 66 : 3 12. (Pubitemid 351188283)
12. Reidy K, Kaskel FJ, Reidy K, Kaskel FJ. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol 2007 : 22 : 350 354. (Pubitemid 46766756)
13. Cho MH, Hong EH, Lee TH, et al. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Nephrology 2007 : 12 (Suppl 3 S11 14.
14. van den Berg JG, Weening JJ, van den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci 2004 : 107 : 125 136.
15. Woroniecki RP, Kopp JB, Woroniecki RP, Kopp JB. Genetics of focal segmental glomerulosclerosis. Pediatr Nephrol 2007 : 22 : 638 644.
16. Franceschini N, North KE, Kopp JB, et al. NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: A HuGE review. Genetics in Medicine 2006 : 8 : 63 75. (Pubitemid 43756040)
17. Baum MA, Baum MA. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004 : 8 : 329 333. (Pubitemid 39062113)
18. Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: Outcomes and response to therapy for recurrence. Transplantation 2009 : 87 : 1232 1239.
19. Pardon A, Audard V, Caillard S, et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006 : 21 : 1053 1059.
20. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972 : 2 : 343 348.
21. Raij L, Hoyer JR, Michael AF. Steroid-resistant nephrotic syndrome: Recurrence after transplantation. Ann Inter Med 1972 : 77 : 581 586.
22. Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999 : 68 : 635 641. (Pubitemid 29453439)
23. Kaplan-Pavlovcic S, Ferluga D, Hvala A, Chwatal-Lakic N, Bren AF, Vizjak A. Recurrent focal segmental glomerulosclerosis after renal transplantation: Is early recurrent proteinuria always a surrogate marker for recurrence of the disease? Transplant Proc 2002 : 34 : 3122 3124. (Pubitemid 35463268)
24. Requiao-Moura LR, Moscoso-Solorzano GT, Franco MF, et al. Prognostic factors associated with poor graft outcomes in renal recipients with post-transplant glomerulonephritis. Clin Transplant 2007 : 21 : 363 370.
25. Sener A, Bella AJ, Nguan C, et al. Focal segmental glomerular sclerosis in renal transplant recipients: Predicting early disease recurrence may prolong allograft function. Clin Transplant 2009 : 23 : 96 100.
26. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992 : 2 : S258 263.
27. Dall'Amico R, Ghiggeri G, Carraro M, et al. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 1999 : 34 : 1048 1055.
28. Huang K, Ferris ME, Andreoni KA, et al. The differential effect of race among pediatric kidney transplant recipients with focal segmental glomerulosclerosis. Am J Kidney Dis 2004 : 43 : 1082 1090. (Pubitemid 38691504)
29. Kim SJ, Ha J, Jung IM, et al. Recurrent focal segmental glomerulosclerosis following renal transplantation in Korean pediatric patients see comment Pediatr Transplant 2001 : 5 : 105 111. (Pubitemid 32298570)
30. Cheong HI, Han HW, Park HW, et al. Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant 2000 : 15 : 78 81.
31. Odorico JS, Knechtle SJ, Rayhill SC, et al. The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation 1996 : 61 : 228 234.
32. Fujisawa M, Iijima K, Ishimura T, et al. Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 2002 : 17 : 165 168. (Pubitemid 36076028)
33. Striegel JE, Sibley RK, Fryd DS, Mauer SM. Recurrence of focal segmental sclerosis in children following renal transplantation. Kidney International - Supplement 1986 : 19 : S44 50.
34. Raafat R, Travis LB, Kalia A, Diven S. Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pediatr Nephrol 2000 : 14 : 189 194. (Pubitemid 30122139)
35. Hubsch H, Montane B, Abitbol C, et al. Recurrent focal glomerulosclerosis in pediatric renal allografts: The Miami experience. Pediatr Nephrol 2005 : 20 : 210 216. (Pubitemid 40174037)
36. Hocker B, Knuppel T, Waldherr R, et al. Recurrence of proteinuria 10 years post-transplant in NPHS2-associated focal segmental glomerulosclerosis after conversion from cyclosporin A to sirolimus. Pediatr Nephrol 2006 : 21 : 1476 1479. (Pubitemid 44283483)
37. Skhiri H, Morelon E, Noel LH, et al. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus. Transpl Int 2005 : 18 : 458 460. (Pubitemid 41726881)
38. Letavernier E, Bruneval P, Mandet C, et al. High sirolimus levels may induce focal segmental glomerulosclerosis de novo see comment Clinical Journal of The American Society of Nephrology: CJASN 2007 : 2 : 326 333.
39. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001 : 59 : 328 333. (Pubitemid 32055241)
40. Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 Annual Renal Transplantation in Children Report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999 : 3 : 152 167. (Pubitemid 29274420)
41. Conlon PJ, Butterly D, Albers F, Rodby R, Gunnells JC, Howell DN. Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis 1995 : 26 : 34 40.
42. Patrakka J, Ruotsalainen V, Reponen P, et al. Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: Role of nephrin see comment Transplantation 2002 : 73 : 394 403.
43. Carraro M, Caridi G, Bruschi M, et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 2002 : 13 : 1946 1952.
44. Obeidova H, Merta M, Reiterova J, et al. Genetic basis of nephrotic syndrome - review. Prague Medical Report 2006 : 107 : 5 16.
45. Bertelli R, Ginevri F, Caridi G, et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003 : 41 : 1314 1321.
46. Caridi G, Dagnino M, Sanna-Cherchi S, Perfumo F, Ghiggeri GM. Podocin-related mechanisms in posttransplant [corrected] recurrence of focal segmental glomerulosclerosis [corrected][erratum appears in Transplant Proc. 2007 Jan-Feb;39(1):314]. Transplant Proc 2006 : 38 : 3486 3490.
47. Weber S, Gribouval O, Esquivel EL, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 2004 : 66 : 571 579.
48. Chua AN, Alexander SR, Sarwal MM, et al. Proteinuria in pediatric renal transplant recipients during the first 60 post-transplant days. Pediatr Transplant 2006 : 10 : 957 961.
49. Mizuiri S, Kawamura T, Miyagi M, et al. Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis - angiotensin II immunostaining and treatment outcome. Clin Transplant 2005 : 14 : 12 19.
50. IJpelaar D, Farris AB, Goemaere N, et al. Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol 2008 : 19 : 2219 2224.
51. D'Cunha PT, Parasuraman R, Venkat KK, D'Cunha PT, Parasuraman R. Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation. Am J Transplant 2005 : 5 : 351 355.
52. Myslak M, Amer H, Morales P, et al. Interpreting post-transplant proteinuria in patients with proteinuria pre-transplant.[see comment]. Am J Transplant 2006 : 6 : 1660 1665.
53. Cattran D, Neogi T, Sharma R, et al. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis see comment J Am Soc Nephrol 2003 : 14 : 448 453.
54. Ghiggeri GM, Artero M, Carraro M, et al. Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence. Pediatr Transplant 2004 : 8 : 339 343.
55. Becker-Cohen R, Bruschi M, Rinat C, et al. Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies. Am J Transplant 2007 : 7 : 256 260.
56. Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974 : 2 : 556 560.
57. Savin VJ, McCarthy ET, Sharma M, Savin VJ, McCarthy ET, Sharma M. Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 2003 : 23 : 147 160.
58. Savin VJ, McCarthy ET, Sharma R, et al. Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl Res 2008 : 151 : 288 292.
59. Sharma M, Sharma R, McCarthy ET, et al. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exp Biol Med 2004 : 229 : 85 98.
60. Schwartz MM. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis. Ren Fail 2000 : 22 : 663 684.
61. Hattori M, Akioka Y, Chikamoto H, et al. Increase of integrin-linked kinase activity in cultured podocytes upon stimulation with plasma from patients with recurrent FSGS. Am J Transplant 2008 : 8 : 1550 1556.
62. Carraro M, Zennaro C, Artero M, et al. The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 2004 : 19 : 1969 1975. (Pubitemid 39139625)
63. Trachtman H, Futterweit S, Singhal PC, et al. Circulating factor in patients with recurrent focal segmental glomerulosclerosis postrenal transplantation inhibits expression of inducible nitric oxide synthase and nitric oxide production by cultured rat mesangial cells. J Investig Med 1999 : 47 : 114 120. (Pubitemid 129541444)
64. Carraro M, Zennaro C, Candiano G, et al. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome. Nephrol Dial Transplant 2003 : 18 : 689 693. (Pubitemid 36432249)
65. Artero ML, Sharma R, Savin VJ, Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994 : 23 : 574 581. (Pubitemid 24109121)
66. Garcia CD, Bittencourt VB, Tumelero A, Antonello JS, Malheiros D, Garcia VD. Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis. Transplant Proc 2006 : 38 : 1904 1905. (Pubitemid 44190082)
67. Greenstein SM, Delrio M, Ong E, et al. Plasmapheresis treatment for recurrent focal sclerosis in pediatric renal allografts. Pediatr Nephrol 2000 : 14 : 1061 1065.
68. Matalon A, Markowitz GS, Joseph RE, et al. Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients. Clin Nephrol 2001 : 56 : 271 278. (Pubitemid 32923160)
69. Otsubo S, Tanabe K, Shinmura H, et al. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients. Ther Apher Dial 2004 : 8 : 299 304. (Pubitemid 39108747)
70. Pradhan M, Petro J, Palmer J, et al. Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 2003 : 18 : 934 938.
71. Valdivia P, Gonzalez Roncero F, Gentil MA, et al. Plasmapheresis for the prophylaxis and treatment of recurrent focal segmental glomerulosclerosis following renal transplant. Transplant Proc 2005 : 37 : 1473 1474.
72. Belson A, Yorgin PD, Al-Uzri AY, Salvatierra O, Higgins J, Alexander SR. Long-term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol 2001 : 16 : 985 989.
73. Gohh RY, Yango AF, Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005 : 5 : 2907 2912.
74. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis see comment N Engl J Med 1996 : 334 : 878 883.
75. Dantal J, Bigot E, Bogers W, et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome see comment N Engl J Med 1994 : 330 : 7 14.
76. Dantal J, Testa A, Bigot E, Soulillou JP. Effects of plasma-protein A immunoadsorption on idiopathic nephrotic syndrome recurring after renal transplantation. Ann Med Interne 1992 : 143 (Suppl 1 48 51.
77. Sharma R, Sharma M, Ge X, McCarthy ET, Savin VJ. Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP. Transplantation 1996 : 62 : 1916 1920.
78. Banfi G, Colturi C, Montagnino G, Ponticelli C. The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation 1990 : 50 : 594 596.
79. Schwarz A, Krause PH, Offermann G, Keller F. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991 : 17 : 524 531.
80. Ingulli E, Tejani A. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children - a single-center experience. Transplantation 1991 : 51 : 401 405.
81. Couloures K, Pepkowitz SH, Goldfinger D, et al. Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: A case report. Pediatr Transplant 2006 : 10 : 962 965.
82. Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida M. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome. Clin Pharmacol Ther 2000 : 68 : 532 540.
83. Hirano T, Akashi T, Oka K, Yoshida M, Matsuno N, Nagao T. Serum cholesterol levels and kidney transplantation outcome: attenuation of cyclosporine efficacy? Transplantation 2001 : 71 : 659 660.
84. Salomon R, Gagnadoux MF, Niaudet P, Salomon R, Gagnadoux M-F, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003 : 75 : 810 814.
85. Raafat RH, Kalia A, Travis LB, et al. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004 : 44 : 50 56.
86. Kessler M, Champigneulles J, Hestin D, Frimat L, Renoult E. A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. Transplantation 1999 : 67 : 641 643.
87. Kershaw DB, Sedman AB, Kelsch RC, Bunchman TE. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: Successful treatment with oral cyclophosphamide. Clin Transplant 1994 : 8 : 546 549.
88. Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 1993 : 7 : 50 54. (Pubitemid 23045337)
89. Pescovitz MD. Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 2006 : 6 : 859 866.
90. Benz K, Dotsch J, Rascher W, et al. Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 2004 : 19 : 794 797. (Pubitemid 38931165)
91. Nozu K, Iijima K, Fujisawa M, et al. Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome.[see comment]. Pediatr Nephrol 2005 : 20 : 1660 1663. (Pubitemid 41554486)
92. Gossmann J, Scheuermann EH, Porubsky S, et al. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 2007 : 20 : 558 562. (Pubitemid 46701081)
93. Hristea D, Hadaya K, Marangon N, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007 : 20 : 102 105.
94. Apeland T, Hartmann A, Apeland T, Hartmann A. Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Nephrol Dial Transplant 2008 : 23 : 2091 2094. (Pubitemid 351768185)
95. Pescovitz MD, Book BK, Sidner RA, Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006 : 354 : 1961 1963. (Pubitemid 43872718)
96. Yabu JM, Ho B, Scandling JD, Vincenti F. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008 : 8 : 222 227.
97. Hoffmann S, Podlich D, Hahnel B, et al. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004 : 15 : 1475 1487. (Pubitemid 38679672)
98. White CT, Macpherson CF, Hurley RM, et al. Antiproteinuric effects of enalapril and losartan: A pilot study. Pediatr Nephrol 2003 : 18 : 1038 1043. (Pubitemid 37236219)
99. Bresnahan BA, McBride MA, Cherikh WS, Hariharan S. Risk factors for renal allograft survival from pediatric cadaver donors: an analysis of united network for organ sharing data. Transplantation 2001 : 72 : 256 261. (Pubitemid 32729345)
100. Humar A, Matas AJ, Humar A, Matas AJ. Surgical complications after kidney transplantation. Seminars in Dialysis 2005 : 18 : 505 510. (Pubitemid 43094229)
101. Biesenbach G, Janko O, Hubmann R, Gross C, Brucke P. The incidence of thrombovenous and thromboembolic complications in kidney transplant patients with recurrent glomerulonephritis is dependent on the occurrence of severe proteinuria. Clin Nephrol 2000 : 54 : 382 387.
102. Morrissey PE, Ramirez PJ, Gohh RY, et al. Management of thrombophilia in renal transplant patients. Am J Transplant 2002 : 2 : 872 876. (Pubitemid 36306843)
103. Friedman GS, Meier-Kriesche HU, Kaplan B, et al. Hypercoagulable states in renal transplant candidates: impact of anticoagulation upon incidence of renal allograft thrombosis. Transplantation 2001 : 72 : 1073 1078. (Pubitemid 32924080)
104. Kusyk T, Verran D, Stewart G, et al. Increased risk of hemorrhagic complications in renal allograft recipients receiving systemic heparin early posttransplantation. Transplant Proc 2005 : 37 : 1026 1028.
105. Torres VE, Velosa JA, Holley KE, Frohnert PP, Zincke H, Sterioff S. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation. Mayo Clin Proc 1984 : 59 : 146 152.
106. Navaneethan SD, Pansini F, Perkovic V, et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev 2009 : CD007784.
107. Fried LF, Fried LF. Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease. Kidney Int 2008 : 74 : 571 576.
108. Abbott KC, Sawyers ES, Oliver JD III., et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001 : 37 : 366 373.